Back to search
FDAFDA · Food and drugs·Recall number Z-1686-2017

Legionella IFA Substrate Slide (IF0951) intended for qualitatively detecting and semi-quantitating human serum antibodies to Legionella pneumophila.

Published April 5, 2017 · Recall initiated: February 15, 2017

Summary

FDA records medical device Class II recall Z-1686-2017, published April 5, 2017 and initiated February 15, 2017. Recalling firm: Focus Diagnostics Inc; Status: Terminated; Reported quantity: 1,400 units; Lot: IF0951: 10816101020055, lot numbers 29428, 31871. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

After a submission for CLIA database update from Focus Diagnostics to DiaSorin Molecular,the company found that their Legionella IFA device (IF0950) is not 510(k) exempt.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Focus Diagnostics Inc
Distributor
Product was distributed to three testing laboratories in California, New Jersey and Virginia
Lot
IF0951: 10816101020055, lot numbers 29428, 31871
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Legionella IFA Substrate Slide (IF0951) intended for qualitatively detecting and semi-quantitating human serum antibodies to Legionella pneumophila. recalled?

Yes. FDA published recall Z-1686-2017 on April 5, 2017. Reported hazard: After a submission for CLIA database update from Focus Diagnostics to DiaSorin Molecular,the company found that their Legionella IFA device (IF0950) is not 510(k) exempt.

What should I do if I have this product?

Voluntary: Firm initiated · Letter